Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background/objectives: Research on the relationship between small-area-level deprivation and cancer survival, particularly for colorectal cancer (CRC), is lacking. Therefore, we investigated the relationship among small area-level deprivation, individual-level factors, and CRC survival using data from the Busan Regional Cancer Registry.

Methods: We analyzed 34,999 patients with CRC from the Busan Regional Cancer Registry from 2003 to 2020. The primary outcome was CRC mortality. The explanatory variables at the individual level included age, gender, cancer stage, and year of diagnosis, whereas the Deprivation Index (DI) was used at the regional level. We conducted a multilevel survival analysis with frailty to assess the impact of individual- and area-level factors on survival probabilities.

Results: In the multilevel survival model, each unit increase in the DI at the area level was associated with a 6.6% decrease in survival probability. When applying Model 2 and deriving regional estimates using the empirical Bayesian estimation method, the graph of the DI (x-axis) against survival probability (y-axis) showed that the slope of the regional DI for the 3-year and 5-year survival probabilities increased compared with the 1-year rate across all stages of the disease. Additionally, the slopes were steeper for the distant stage than for the local or regional stages.

Conclusions: Small-area level deprivation negatively affects CRC survival, especially in distant-stage patients and those with longer disease duration.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11852685PMC
http://dx.doi.org/10.3390/cancers17040567DOI Listing

Publication Analysis

Top Keywords

regional cancer
12
survival
10
area level
8
level deprivation
8
colorectal cancer
8
cancer survival
8
cancer registry
8
crc survival
8
busan regional
8
multilevel survival
8

Similar Publications

People with severe mental illness die 10-20 years earlier than the general population, mostly from preventable physical diseases. Fragmented care, under-screening and undertreatment of cardiovascular, respiratory, infectious and cancer conditions widen this gap. Embedding physical screening, proactive treatment, smoking cessation, cancer checks and multidisciplinary, person-centred care into psychiatric services could close this mortality divide.

View Article and Find Full Text PDF

Tahiti or the "myth of Paradise", Bora Bora, "the Pearl of the Pacific". Who has never wanted to take a plane and come and land on the heavenly beaches of Polynesia, a French territory at the antipodes of mainland France lost in the middle of the Pacific? However, we do not imagine that 60% of Polynesians live below the metropolitan low-income threshold or that life expectancy is lower than that of the mainland due to the high prevalence of cardiovascular diseases with three quarters overweight population.In addition to non-transmissible metabolic diseases, various pathologies common to temperate countries present specificities in Polynesia, leading to sometimes different management and medical reasoning.

View Article and Find Full Text PDF

Digital twins in nuclear medicine: A proposition of a modular pipeline for dosimetry protocol optimization in molecular radiotherapy.

Comput Struct Biotechnol J

August 2025

Institut de Recherche en Cancérologie de Montpellier (IRCM), Équipe Labellisée Ligue Contre le Cancer, INSERM U1194, Université de Montpellier, Institut régional du Cancer de Montpellier (ICM), Montpellier, France.

Digital twins (DTs) are emerging tools for simulating and optimizing therapeutic protocols in personalized nuclear medicine. In this paper, we present a modular pipeline for constructing patient-specific DTs aimed at assessing and improving dosimetry protocols in PRRT such as therapy. The pipeline integrates three components: (i) an anatomical DT, generated by registering patient CT scans with an anthropomorphic model; (ii) a functional DT, based on a physiologically-based pharmacokinetic (PBPK) model created in SimBiology; and (iii) a virtual clinical trial module using GATE to simulate particle transport, image simulation, and absorbed dose distribution.

View Article and Find Full Text PDF

The Oncotype DX test is standardly used for patients with early-stage, hormone-receptor-positive, HER2-negative breast cancers to determine the benefit from chemotherapy and the likelihood of distant recurrence. The relationship between Oncotype DX recurrence scores and race/ethnicity is still being studied. This retrospective study aims to evaluate the relationship between Oncotype DX recurrence scores, race/ethnicity, and clinicopathological factors and to support the applicability of the Oncotype DX test for a diverse breast cancer population of Hawaii.

View Article and Find Full Text PDF

Purpose: Identifying radiomics features that help predict whether glioblastoma patients are prone to developing epilepsy may contribute to an improvement of preventive treatment and a better understanding of the underlying pathophysiology.

Materials And Methods: In this retrospective study, 3-T MRI data of 451 pretreatment glioblastoma patients (mean age: 61.2 ± 11.

View Article and Find Full Text PDF